Medifast, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Medifast, Inc. (MED) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-05-04
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $0.00.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-09-30 was $0.00.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $15.00K, a 96.59% decline from fiscal 2023.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $440.00K.
- Medifast, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | ||||||
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 | ||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | $0.00 derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $15.00K 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $15.00K 10-Q · filed 2025-11-03 | $127.00K derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $15.00K 10-Q · filed 2025-08-04 | $127.00K derived: sum of 3 quarters · filed 2026-02-17 | $127.00K derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-03-31 | $15.00K 10-Q · filed 2025-04-28 | $127.00K derived: sum of 2 quarters · filed 2026-02-17 | $127.00K derived: sum of 3 quarters · filed 2026-02-17 | $127.00K derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2023-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $112.00K derived: sum of 2 quarters · filed 2026-02-17 | $112.00K derived: sum of 3 quarters · filed 2026-02-17 | $440.00K 10-K · filed 2026-02-17 | $400.00K 10-K · filed 2024-02-20 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $328.00K 10-Q · filed 2024-11-04 | $300.00K 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $328.00K 10-Q · filed 2024-08-05 | $300.00K 10-Q · filed 2023-08-07 | ||||
| 2023-03-31 | $328.00K 10-Q · filed 2024-04-29 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 | ||||||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-01 | $2.90M derived: sum of 2 quarters · filed 2024-02-20 | |||||
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $5.90M 10-K · filed 2024-02-20 | |||||
| 2021-09-30 | $3.30M 10-Q · filed 2022-11-03 | ||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $1.40M 10-Q · filed 2018-11-07 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.40M 10-Q · filed 2018-08-06 | |||||
| 2018-03-31 | $1.40M 10-Q · filed 2018-05-04 | ||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $325.00K 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $325.00K 10-Q · filed 2018-08-06 | |||||
| 2017-03-31 | $325.00K 10-Q · filed 2018-05-04 | ||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $67.00K derived: sum of 2 quarters · filed 2017-11-08 | $69.00K 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $69.00K 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | $2.00K 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |